Novel substituted 5-arylidene-1, 3-thiazolidin-4-one analogues: Synthesis, optimization, anticancer screening and docking studies. (2022). Journal of Pharmaceutical Negative Results, 2378-2389. https://doi.org/10.47750/pnr.2022.13.S06.310